Calvarial metastasis of renal cell carcinoma. En savoir plus sur Calvarial metastasis of renal cell carcinoma.
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. En savoir plus sur Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Autism spectrum disorder associated with 49,XYYYY: case report and review of the literature. En savoir plus sur Autism spectrum disorder associated with 49,XYYYY: case report and review of the literature.
How minimally invasive vestibular neurotomy for incapacitating Meniere's disease improves dizziness and anxiety. En savoir plus sur How minimally invasive vestibular neurotomy for incapacitating Meniere's disease improves dizziness and anxiety.
Signal-intensity-ratio MRI accurately estimates hepatic iron load in hemodialysis patients. En savoir plus sur Signal-intensity-ratio MRI accurately estimates hepatic iron load in hemodialysis patients.
The medical value and cost-effectiveness of an exercise test for sport preparticipation evaluation in asymptomatic middle-aged white male and female athletes. En savoir plus sur The medical value and cost-effectiveness of an exercise test for sport preparticipation evaluation in asymptomatic middle-aged white male and female athletes.
Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension). En savoir plus sur Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
Thrombosis of venous outflows of the cavernous sinus: possible aetiology of the cortical venous reflux in case of indirect carotid-cavernous fistulas. En savoir plus sur Thrombosis of venous outflows of the cavernous sinus: possible aetiology of the cortical venous reflux in case of indirect carotid-cavernous fistulas.
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients. En savoir plus sur Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.